Skip to main content
. 2022 Dec 5;68(12):1611–1618. doi: 10.1590/1806-9282.022D6812

Table 2. Grade table for evaluating the level of evidence.

Certainty assessment N o of patients Effect Certainty Importance
N o of studies Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations Intervention (%) Comparison (%) Relative (95%CI) Absolute (95%CI)
1. Linear wear (mm/y) XLPE
9 Randomized trials Serious a,b Not serious Not serious Not serious None 448 443 MD 0 (0.01 minor to 0) ⊕⊕⊕◯ moderate
2. Linear wear (mm/y) UHMWPE
4 Randomized trials Serious a,b Not serious Not serious Not serious None 67 71 MD 0 (0.04 minor to 0.05 higher) ⊕⊕⊕◯ moderate
3. Surgical reviews
7 Randomized trials Serious a,b Not serious Not serious Serious c None 2/400 (0.5) 5/400 (1.3) Not estimable 10 more for 1.000 (from 10 less to 20 more) ⊕⊕◯◯ low
4. Head size
11 Randomized Trials Very serious a,b,d Very serious e Very serious e Serious c None 518 536 SMD 0.75 higher (0.52 lowest to 2.03 highest) ⊕◯◯◯ very low
5. Harris hip score (HHS)
5 Randomized trials Very serious a,b,d Not serious Not serious Serious c None 147 155 MD 5.02 smaller (7.3 minor to 2.73 minor) ⊕◯◯◯ very low

CI: confidence interval; SMD: standardized mean difference.

a

Absence of analysis by intention of treatment;

b

Absence of blinding;

c

Long confidence interval;

d

Absence of sample calculation;

e

High heterogeneity.